SkyQuest Technology Group recently introduced Injection Pen Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Injection Pen Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Injection Pen Market size was valued at USD 48.57 Billion in 2023 and is poised to grow from USD 52.42 Billion in 2024 to USD 96.52 Billion by 2032, growing at a CAGR of 7.93% during the forecast period (2025-2032).
Growing rates of chronic illnesses including diabetes and cancer, as well as an increase in the number of elderly people, are the main drivers of the global injection pen market. Thus, the two main reasons propelling the injection pen market growth are the rise in awareness of self-injectable devices and the incidence of chronic diseases. Additionally, the primary driver of market expansion is the growing use of reusable injectable pen with improved technology among diabetic patients. For example, Medtronic Plc introduced the InPen, a reusable smart injectable pen for diabetics, in 2020.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/injection-pen-market
The pen estimates the number of carbs in meals and computes insulin dosages using Bluetooth technology. Reciprocating that injection pen market share is growing due to the increasing usage of automated injection pen. Healthcare providers increasingly favor automated injection pen as they can administer medication to patients accurately, safely, and conveniently. Due to the rapidly growing number of elderly people who are more susceptible to chronic illnesses like diabetes and cancer, the need for injectable pen is not just in developed nations but is also being seen in developing nations. These are the elements that drive the injection pen industry expansion.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Injection Pen Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Type
Disposable Injection Pens, Reusable Injection Pens
Therapy
Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility, Obesity, Other Therapies
End User
Home Care Settings, Hospitals & Clinics
Injection Pen Market – Regional Analysis:
– Injection Pen North America Market includes (Canada, Mexico, USA)
– Injection Pen Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Injection Pen Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Injection Pen South America Market includes (Brazil, Argentina)
– Injection Pen Oceania Market (Australia & New Zealand)
Top Market Players in Injection Pen Market are:
Novo Nordisk A/S (Denmark)
Eli Lilly And Company (US)
Sanofi (France)
Ypsomed Holding AG (Switzerland)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
AstraZeneca (UK)
Owen Mumford (UK)
Sun Pharmaceutical Industries Ltd (India)
Pfizer Inc. (US)
Biocon (India)
Lupin (India)
Wockhardt Ltd. (India)
Medtronic (US)
Gerresheimer AG (Germany)
Shaily Engineering Plastics Ltd. (India)
SHL Medical AG (Switzerland)
Emperra GmbH E-Health Technologies (Germany)
Nemera France SAS (France)
Jiangsu Delfu Medical Device Co., Ltd. (China)
Solteam Medical (China)
Stevanato Group (Italy)
Wanhai Medical Instruments Co., Ltd. (China)
Injection Pen Market Recent Developments:
In July 2024, Sanofi lauded the SoloSTAR 2 as a new design of an insulin pen changing the entire perspective to the functionality of the pen. The insulated flow injector has a simplified dose dial and a larger display. This however, is aimed at the overall user satisfaction with the diabetic patients who use insulin therapy.
In September 2024, Eli Lilly announced its new SmartPen technology, which is meant to be adopted into a digital health ecosystem. This injection pen helps patients in tracking their doses in real-time, and this enables improved interaction with medical practitioners and adjusting treatment regimens for better and effective management of diabetes.
Also Read –
https://www.skyquestt.com/report/nail-care-products-market
https://www.skyquestt.com/report/smart-pillows-market
Forward-Looking Insights
The Injection Pen Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
